Isabelle Davignon

1.2k total citations
19 papers, 1000 citations indexed

About

Isabelle Davignon is a scholar working on Pharmacology, Rheumatology and Molecular Biology. According to data from OpenAlex, Isabelle Davignon has authored 19 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Rheumatology and 6 papers in Molecular Biology. Recurrent topics in Isabelle Davignon's work include Osteoarthritis Treatment and Mechanisms (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Isabelle Davignon is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (9 papers), Inflammatory mediators and NSAID effects (8 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Isabelle Davignon collaborates with scholars based in United States, Canada and United Kingdom. Isabelle Davignon's co-authors include Christine R. West, Michael D. Smith, Frederick T. Murphy, Thomas M. Wilkie, Mark T. Brown, Serguei Popov, Xin Xu, Shmuel Muallem, M. Brown and Weizhong Zeng and has published in prestigious journals such as JAMA, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Isabelle Davignon

19 papers receiving 987 citations

Peers

Countries citing papers authored by Isabelle Davignon

Since Specialization

Citations

This map shows the geographic impact of Isabelle Davignon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Davignon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Davignon more than expected).

Fields of papers citing papers by Isabelle Davignon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Davignon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Davignon. The network helps show where Isabelle Davignon may publish in the future.

Co-authorship network of co-authors of Isabelle Davignon

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Davignon. A scholar is included among the top collaborators of Isabelle Davignon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Davignon. Isabelle Davignon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Time to first and sustained improvement in WOMAC domains among patients with osteoarthritis receiving tanezumab 2022 ·SHILAP Revista de lepidopterología ·David J. Hunter, Thomas J. Schnitzer, Jerry Hall, (unknown), Isabelle Davignon, Joseph C. Cappelleri, Andrew G. Bushmakin, Lucy Abraham	1
2	Single and Composite Endpoints of Within-Patient Improvement in Symptoms: Pooled Tanezumab Data in Patients with Osteoarthritis 2021 ·Rheumatology and Therapy ·Thomas J. Schnitzer, Francis Bérenbaum, Philip G. Conaghan, Robert H. Dworkin, Davide Gatti, Ruoyong Yang, Lars Viktrup, Isabelle Davignon, Christine R. West, Kenneth M. Verburg	3
3	General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo‐Controlled Trials 2021 ·Arthritis Care & Research ·Francis Bérenbaum, Thomas J. Schnitzer, Alan Kivitz, Lars Viktrup, Anne Hickman, Glenn C. Pixton, Mark T. Brown, Isabelle Davignon, Christine R. West	7
4	Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study 2020 ·Seminars in Arthritis and Rheumatism ·Thomas J. Schnitzer, Arifulla Khan, Louis Bessette, Isabelle Davignon, Mark T. Brown, Glenn C. Pixton, (unknown), Leslie Tive, Lars Viktrup, Christine R. West	15
5	Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip 2019 ·Osteoarthritis and Cartilage ·Louis Bessette, Thomas J. Schnitzer, A Khan, Glenn C. Pixton, Lars Viktrup, Isabelle Davignon, Leslie Tive, M. Brown, Christine R. West	1
6	Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee 2019 ·JAMA ·Thomas J. Schnitzer, Richard Easton, Shirley Pang, Dennis J. Levinson, Glenn C. Pixton, Lars Viktrup, Isabelle Davignon, M. Brown, Christine R. West, Kenneth M. Verburg	136
7	Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial 2013 ·Annals of the Rheumatic Diseases ·Andra Bălănescu, Eugen Feist, G Wolfram, Isabelle Davignon, Michael D. Smith, Mark T. Brown, Christine R. West	76
8	Tanezumab Reduces Osteoarthritic Hip Pain: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase III Trial 2013 ·Arthritis & Rheumatism ·M. Brown, Frederick T. Murphy, (unknown), Isabelle Davignon, Michael D. Smith, Christine R. West	106
9	Tanezumab Reduces Osteoarthritic Knee Pain: Results of a Randomized, Double-Blind, Placebo-Controlled Phase III Trial 2012 ·Journal of Pain ·Mark T. Brown, Frederick T. Murphy, (unknown), Isabelle Davignon, Michael D. Smith, Christine R. West	161
10	Cloning and characterization of the G protein βγ subunits from Trichoplusia ni (High Five™ cells) 2005 ·Insect Biochemistry and Molecular Biology ·(unknown), (unknown), Isabelle Davignon, Julie Collins, Roger K. Sunahara	3
11	Normal Hematopoiesis and Inflammatory Responses Despite Discrete Signaling Defects in Gα15 Knockout Mice 2000 ·Molecular and Cellular Biology ·Isabelle Davignon, Michelle D. Catalina, (unknown), Jennifer Montgomery, Jennifer L. Swantek, (unknown), Mark Siegelman, Thomas M. Wilkie	32
12	Alternate Coupling of Receptors to Gs and Gi in Pancreatic and Submandibular Gland Cells 1999 ·Journal of Biological Chemistry ·Xiang Luo, Weizhong Zeng, Xin Xu, Serguei Popov, Isabelle Davignon, Thomas M. Wilkie, Susanne M. Mumby, Shmuel Muallem	55
13	RGS Proteins Determine Signaling Specificity of Gq-coupled Receptors 1999 ·Journal of Biological Chemistry ·Xin Xu, Weizhong Zeng, Serguei Popov, David M. Berman, Isabelle Davignon, Kan Yu, David Yowe, Stefan Offermanns, Shmuel Muallem, Thomas M. Wilkie	227
14	Promiscuous Coupling of Receptors to Gq Class α Subunits and Effector Proteins in Pancreatic and Submandibular Gland Cells 1998 ·Journal of Biological Chemistry ·Xin Xu, (unknown), (unknown), Liping Zhao, Isabelle Davignon, Serguei Popov, Kan Yu, Huiping Jiang, Stefan Offermanns, Shmuel Muallem, Thomas M. Wilkie	40
15	Gene Structure of MurineGna11andGna15:Tandemly Duplicated Gq Class G Protein α Subunit Genes 1996 ·Genomics ·Isabelle Davignon, (unknown), Oksana Gavrilova, (unknown), Thomas M. Wilkie	24
16	Insulin‐like growth factor‐l blood levels in severely burned patients: effects of time post injury, age of patient and severity of burn 1993 ·Clinical Endocrinology ·Thierry Abribat, Paul Brazeau, Isabelle Davignon, Dominique R. Garrel	58
17	No change in glucose tolerance and substrate oxidation after a high-carbohydrate, low-fat diet 1993 ·Metabolism ·Isabelle Leclerc, Isabelle Davignon, (unknown), Dominique R. Garrel	12
18	Length of Care in Patients with Severe Burns with or without Early Enteral Nutritional Support 1991 ·Journal of Burn Care & Rehabilitation ·Carol Ireton‐Jones, Dominique R. Garrel, Isabelle Davignon, (unknown)	35
19	Dietary habits after ileal pouch-anal anastomosis. 1990 ·PubMed ·Carl Chartrand‐Lefebvre, Jacques Heppell, Isabelle Davignon, Shishir Dube, Alfons Pomp	8

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact